Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NasdaqGS - Nasdaq Real Time Price USD

Amedisys, Inc. (AMED)

Compare
92.84
+0.21
+(0.23%)
At close: April 1 at 4:00:01 PM EDT
92.11
-0.73
(-0.79%)
Pre-Market: 6:09:42 AM EDT
Loading Chart for AMED
  • Previous Close 92.63
  • Open 92.36
  • Bid 84.92 x 100
  • Ask 100.00 x 100
  • Day's Range 91.48 - 93.03
  • 52 Week Range 82.15 - 98.95
  • Volume 322,083
  • Avg. Volume 320,651
  • Market Cap (intraday) 3.046B
  • Beta (5Y Monthly) 0.76
  • PE Ratio (TTM) 70.87
  • EPS (TTM) 1.31
  • Earnings Date Apr 22, 2025 - Apr 28, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 97.38

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.

www.amedisys.com

19,000

Full Time Employees

December 31

Fiscal Year Ends

Recent News: AMED

View More

Performance Overview: AMED

Trailing total returns as of 4/1/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

AMED
2.26%
S&P 500 (^GSPC)
4.23%

1-Year Return

AMED
0.45%
S&P 500 (^GSPC)
7.42%

3-Year Return

AMED
46.60%
S&P 500 (^GSPC)
23.92%

5-Year Return

AMED
46.31%
S&P 500 (^GSPC)
128.01%

Compare To: AMED

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: AMED

View More

Valuation Measures

Annual
As of 4/1/2025
  • Market Cap

    3.05B

  • Enterprise Value

    3.20B

  • Trailing P/E

    70.87

  • Forward P/E

    20.12

  • PEG Ratio (5yr expected)

    1.34

  • Price/Sales (ttm)

    1.31

  • Price/Book (mrq)

    2.68

  • Enterprise Value/Revenue

    1.36

  • Enterprise Value/EBITDA

    18.05

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.84%

  • Return on Assets (ttm)

    6.24%

  • Return on Equity (ttm)

    3.32%

  • Revenue (ttm)

    2.35B

  • Net Income Avi to Common (ttm)

    43.23M

  • Diluted EPS (ttm)

    1.31

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    303.24M

  • Total Debt/Equity (mrq)

    38.92%

  • Levered Free Cash Flow (ttm)

    277.51M

Research Analysis: AMED

View More

Company Insights: AMED

Research Reports: AMED

View More

People Also Watch